✦ LIBER ✦

RC0639: phase II study of paclitaxel, trastuzumab, and lapatinib as adjuvant therapy for early stage HER2-positive breast cancer

✍ Scribed by Alvaro Moreno-Aspitia,Amylou C. Dueck…

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

PCN61 COST-EFFECTIVENESS OF 1-YEAR ADJUV

✍ T.T.T. Nguyen; R. Yagudina; A.U. Kulikov 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 60 KB

A phase Ib study of preoperative lapatin

✍ In Hae Park, Keun Seok Lee, Han-Sung Kang, Seok Won Kim, Seeyoun Lee, So-Youn Ju 📂 Article 📅 2011 🏛 Springer US 🌐 English ⚖ 158 KB

Phase II trial of preoperative paclitaxe

✍ Seock-Ah Im; Keun Seok Lee; Jungsil Ro; Eun Sook Lee; Youngmee Kwon; Jin-Hee Ahn 📂 Article 📅 2011 🏛 Springer US 🌐 English ⚖ 338 KB

Randomized Phase II Trial of weekly pacl

✍ Giampietro Gasparini; Massimo Gion; Luigi Mariani; Paola Papaldo; Diana Crivella 📂 Article 📅 2006 🏛 Springer US 🌐 English ⚖ 222 KB

PCN4 BUDGET IMPACT ANALYSIS OF ADJUVANT

✍ E Orlewska; R Aultman; M Krzakowski; T Pienkowski; K Drosik; M Szkultecka-Debek 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 70 KB

PCN7 COST-EFFECTIVENESS ANALYSIS OF ADJU

✍ E Orlewska; T Pienkowski; K Drosik; M Gyldmark; R Aultman; M Szkultecka-Debek 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 68 KB